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Purpose: When investigating a case of unexplained corneal ulceration, we need to think of 
fungal infection and any predisposing factors.
Methods: A case study of a corneal ulceration in a patient who was HIV positive with a 
devastating visual outcome.
Results: Therapeutic corneal graft was necessary due to corneal perforation. Immunocompro-
mised state of patient was retrospectively diagnosed.
Conclusions: Candida albicans keratitis is an opportunistic infection of a compromised cornea, 
and sometimes unknowingly compromised host, which can be initially misdiagnosed. Despite 
intensive antifungal therapy, occasionally patients require corneal grafting to improve vision, 
and before it is possible to establish an accurate diagnosis.
Keywords: fungal keratitis, corneal perforation, keratoplasty, human immunodeficiency 
virus, HIV
Introduction
Fungal keratitis was first described by Leber in 1879. It is an uncommon cause of 
corneal infection. If undiagnosed or misdiagnosed, it can lead to devastating visual 
consequences. The reason we decided to publish this case report is to show the potential 
blindness from corneal injury in an immunocompromised patient.
The incidence of fungal keratitis varies according to geographical location and 
ranges from 2% of keratitis in New York to 35% in Florida.1 Fusarium species are the 
most common cause of fungal infection in sorthern US (45%–76% of fungal kera-
titis) while Candida and Aspergillus species are most common in Northern US. It 
must be noted that North East US and the UK are considered temperate regions with 
similar climates. In a study at the New York Eye and Ear Infirmary,2 21% of patients 
with fungal keratitis were found to be HIV positive. In the UK, in a study by Tuft and 
Tullo3 in the period 2003–2005, only one patient was known to be HIV positive, and 
in another retrospective study by Galarreta et al4 over a 13-year period, there were no 
patients with fungal keratitis in their series known to be HIV positive.
In Africa, a study at Muhimbili Medical Centre5 compared the prevalence of HIV 
infection between patients with fungal keratitis and those with nonfungal keratitis; 
81.2% of cases with fungal keratitis were found to be HIV positive, while only 33% 
of those with nonfungal keratitis were HIV positive.
Risk factors for fungal keratitis are young male, healthy, no significant ocular 
disease, and previous history of trauma (vegetable matter) in agricultural occupations 
and contact lens users.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Risk factors for Candida keratitis include: older patient, 
pre-existing ocular disease, exposure keratopathy, foreign 
body, corneal surgery, chronic keratitis, chronic use of 
steroids, and immunosuppressive disease. The relative risk 
for corneal ulceration in one study was 8.8 in HIV-infected 
individuals compared to non-HIV-infected individuals.6
Clinical features of fungal keratitis include a dull white 
appearance to the cornea with associated epithelial heaping, 
grey-white infiltrates with feathery margins, rough tex-
ture, raised borders, brown pigmentation, and associated 
endothelial plaques. Satellite lesions may occur around the 
primary infiltrate, and hypopyon may also be present.
There are numerous diagnostic tests that can be helpful in 
identifying fungal elements. Of them, culture in sabouraud 
dextrose agar, blood agar, and thioglycolate broth can grow 
fungi.
Methods
A 36-year-old female patient presented to our Eye Casualty 
Department complaining of severe pain in the right eye and 
a decreased vision of 24-hour duration. She was generally 
fit and well with past medical history of depression and bar 
investigations for multiple cervical lymph node enlargement 
in 2004. The patient wasn’t on any kind of medication at the 
time. The patient’s history was vague, describing getting 
in contact with a chemical solution (diluted bleach) while 
cleaning her kitchen surfaces, after rubbing her eyes with 
the back of her gloves. Immediately following the incident, 
she irrigated the eyes thoroughly with water for 10 minutes 
at home. On presenting to the eye clinic, her acuities with 
glasses were 6/36 right eye, and 6/6 left eye (Snellen’s 
Acuity Chart). Since there was a history of chemical injury, 
a litmus pH paper was used, but the tear film was neutral.7 
The right eye was injected, with mucopurulent discharge, and 
an edematous cornea with central corneal ulcer measuring 
1.5 mm × 1 mm and associated hypopyon.
The patient was admitted to hospital, corneal scrapings 
were taken, and antibiotic treatment was initiated with 
ciprofloxacin eye drops 0.3% hourly and atropine 1% BD. 
There was no growth of any microorganisms from the initial 
corneal scrapings.
For social reasons, the patient took her own discharge 
and was lost to follow up until she presented to eye casualty 
10 days later with deterioration of her symptoms.
At that stage, right eye vision had reduced to hand 
movements. Corneal ulcer size was 1 mm in diameter, and 
there was no hypopyon. On the basis of the previous history 
of negative corneal scrapings and our assumption of eye 
  exposure to an alkaline agent, the patient was re-admitted 
and started on prednisolone tablets 40 mg/day PO and 
minims dexamethasone 0.1% hourly, vitamin C tablets 3 g 
daily and guttae vitamin C QDS, guttae gentamicin 0.3% 
2 hourly, guttae atropine sulfate 1% TDS, and guttae Ilube 
5% QDS. Over the course of the next 3 days the size of the 
ulcer reduced significantly.
Heavy growth of Candida albicans, sensitive to ampho-
tericin B was shown on corneal scrapings cultures done on 
the second admission. Treatment was changed and the patient 
was started on guttae amphotericin B lipidic emulsion hourly, 
with debridement of the corneal epithelial debris prior to 
application, along with tablet ketoconazole 200 mg OD.
Over the next 3 days, the size of the ulcer continued to 
increase and systemic ketoconazole was discontinued and 
intravenous amphotericin B was initiated. That seemed to 
control the infection, but unfortunately 4 days later the cornea 
spontaneously perforated (Figure 1), and a right therapeutic 
penetrating keratoplasty was performed.
Intra-operatively, the host cornea was adherent to the 
anterior crystalline lens capsule and during corneal trephina-
tion, the lens nucleus was expressed. The soft lens matter was 
aspirated and the keratoplasty was completed leaving the eye 
aphakic (Figure 2). The host cornea was sent for microbiol-
ogy and histopathology, and the results did not reveal any 
organisms, and therefore topical and systemic amphotericin 
B was stopped. Ocular B-scan showed no choroidal or retinal 
detachments. A week later, as the condition of the graft was 
improving, right eye vision was counting fingers with no 
improvement with pinhole. The patient was allowed home 
with guttae chloramphenicol QDS, Ilube 5%.
The patient was lost to follow ups due to social reasons 
and we never knew what her visual outcomes were, but it was 
counting fingers the day before she took her own discharge. 
Figure 1 Perforation of corneal ulcer.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Later on, the patient was contacted by a specialist in genito-
urinary medicine, requesting her to attend for a sexual health 
screen. It seems that our patient had had sexual contact with 
a patient who had recently been diagnosed with HIV a few 
months before the ocular infection appeared. A full sexual 
health screen showed a reactive fourth-generation HIV test,7 
which when repeated confirmed a positive for HIV . This was 
the patient’s first HIV test.
Our patient was expected to undergo immune reconsti-
tution and viral suppression as a response to highly active 
antiretroviral treatment (HAART), but we were unable to 
contact her, and we were informed that she was having a 
difficult time coping socially with her illness.
We have no knowledge whether our patient developed 
HIV infection before or after the fungal keratitis episode. 
However due to the low CD4+ cell count and high viral 
load, we can assume that she was an HIV patient prior to 
corneal infection.
Discussion
According to our literature and Internet search (PubMed, 
Medscape, and Medline), there was only 1 case, published 
by Tuft and Tullo,3 of fungal keratitis associated with HIV in 
the last 15 years in the UK. The retrospective study by Moor-
fields Eye Hospital,4 over a period of 13 years revealed no 
patients in their series known to be HIV positive. However, 
it appears their HIV status was not checked for.
National HIV testing guidelines published in 2008 recom-
mended increased HIV testing in non-HIV specialties and 
suggest particular conditions which should raise suspicion 
of underlying infection.8
So is it true that the rate of HIV and Candida albicans 
keratitis is so low in the UK, or are we simply not look-
ing for them? In Barnsley Hospital, we had one case of 
  Candida albicans keratitis, and the patient was HIV posi-
tive. Retrospectively, we might find the incidence of HIV 
in patients with Candida albicans keratitis to be higher, if 
it was screened for.
Candida albicans keratitis is a challenge for ophthal-
mologists due to its tendency to mimic other conditions. 
Frequently, cases are misdiagnosed at initial presentation,9 
resulting in loss of valuable time in treatment. Misdiagno-
sis may be due to its uncommon occurrence. Further, it is 
practically impossible to differentiate a bacterial keratitis 
from Candida albicans keratitis on clinical appearance only, 
especially in advanced cases. Candida albicans keratitis 
is an opportunistic infection of an already compromised 
cornea; thus, the clinical appearance can be deceiving, 
lacking the trademark corneal lesions features we expect to 
see. Due to their slow progression and failure to resolve on 
antibacterial treatment, Candida albicans keratitis is often 
misdiagnosed as herpetic or amebic.
Corneal scrapings have a major role in misdiagnosis, 
due to the small amount of corneal material obtained as they 
are mostly done by junior doctors. If results of cultures are 
negative but corneal ulcer is persistent, a biopsy should be 
performed. Microbiological detection of fungal filaments in 
corneal scrapings can vary from 35% to 95%.10 A deep cor-
neal biopsy is necessary to obtain tissue for laboratory stud-
ies. A significant amount of patients are inadvertently using 
topical steroid drops by the time diagnosis is established,4 
with detrimental effect on the prognosis and final visual 
outcome. This is clearly highlighted in our case, where his-
tory of eye exposure to an alkaline agent had led us to the 
inadvertent use of systemic and topical steroids with an initial 
favorable response. Since litmus paper pH was neutral, topi-
cal steroids were unnecessary. 
The first corneal scraping was negative. When the results 
from the second culture showed Candida albicans, appropri-
ate amendments were done to the treatment with initiation of 
systemic and topical amphotericin B lipidic emulsion, and 
discontinuation of topical and oral steroids.
Amphotericin B is frequently the treatment of choice 
for Candida infections and related fungi, while miconazole, 
ketoconazole, itraconazole, and fluconazole can be admin-
istered by various routes.11 Some fungal infections can be 
unresponsive to treatment, and according to Lalitha et al,12 
we can identify risk factors at diagnosis that can serve as 
prognostic indicators of primary treatment failure in cases 
of fungal keratitis. Perforation of cornea in cases of fungal 
keratitis can be a risk factor when an ulcer of .14 mm2 is 
present, associated with hypopyon of .2 mm, and the patient 
Figure 2 Tectonic/therapeutic corneal graft.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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is in monotherapy (on topical antifungal drops only). It is not 
possible to achieve the ocular therapeutic level of antifungal 
needed by local treatment only. The corneal penetration of 
all antifungal medications is poor, and even with debride-
ment of the corneal epithelium, the effect is minimal. High 
concentrations can only be achieved with systemic antifungal 
treatment.
Unfortunately, when medical therapy fails, surgical inter-
vention is the only solution. About 25% of fungal keratitis 
infections will eventually need penetrating keratoplasty.13 In 
our case, perforation of the cornea led to us to do penetrat-
ing keratoplasty. Visual prognosis in these cases is often 
poor especially in drug abuse.14 Penetrating keratoplasty is a 
recognized and effective treatment in cases of severe fungal 
keratitis unresponsive to antifungal medication. Penetrat-
ing keratoplasty is even more beneficial when performed 
early.15
HIV disease in the modern era has very good outcomes, 
especially if detected early in the course of disease. Interven-
tions using HAART have been shown to provide risk reduc-
tion from AIDS and death of up to 97%.16,17 National HIV 
testing guidelines published in 2008 in the UK recommend 
increased HIV testing in non-HIV specialties.8
In our case, further tests showed an initial CD4 count 
was 137(%) cells/mm3 (normal value is between 700 and 
1000 cells/mm3), showing significant immunosuppression 
and a very high viral load of well over 4 million copies/mL. 
Genitourinary medicine physicians informed us about her 
HIV status and how this might affect further management 
of her corneal disease.
Most common causes of infectious keratitis in HIV-
positive patients18 are varicella-zoster virus (VZV) and 
herpes simplex virus (HSV). Both of them can establish 
latency after primary infection with subsequent reactiva-
tion when the immune system of the host is compromised. 
In VZV , clinical course includes subepithelial infiltrates, 
stromal keratitis, disciform keratitis, uveitis, and increased 
intraocular pressure. Varicella keratitis is a self-limited 
disease. Corneal scarring may occur, but it is rare. Stromal 
keratitis and uveitis occur in fewer than 10% of the patients 
with primary HSV infection. Blepharoconjunctivitis may 
occur in patients with recurrent ocular HSV infection; 
it may or may not be associated with epithelial keratitis. 
Other complications of HSV infection include dendritic 
and geographic epithelial keratitis, nonnecrotizing stromal 
keratitis, and iridocyclitis.
Candida species are the most common fungal organisms 
causing keratitis in HIV-positive patients. Nonfilamentous 
fungi (Candida) can present in already compromised eyes, 
while filamentous fungi (Fusarium, Aspergillus) are seen in 
association with trauma with vegetable matter. Fungal kera-
titis may be complicated by uveitis, endophthalmitis, and/or 
retinitis. These complications may cause vitreous abscesses, 
retinal hemorrhages with or without Roth spots. In severe 
cases, retinal detachment may develop. Microsporidia is an 
opportunistic infectious protozoon. These are intracellular 
parasites capable of causing corneal infection. Superficial 
keratoconjunctivitis is the most common complication seen 
in HIV-positive patients infected with microsporidia.
It is believed that the outcome of these ocular infections 
can be predicted from the CD4+ cell count. A count of over 
200 cells/mm3 is considered to provide a good prognosis. How-
ever, there is active research on this topic at the moment.
HAART19 was initiated in the form of Truvada (tenofovir 
and emtricitabine) and Kaletra (lopinavir/ritonavir). This 
treatment is ongoing with a positive response. A recent 
study suggested a survival benefit of more than 13 years in 
patients with an AIDS-defining illness and over 25 years in 
those with non-AIDS HIV .20
Conclusion
This case report highlights the fact that Candida albicans 
external ocular disease associated with HIV can often be 
overlooked, leading to significant delays in diagnosis and 
initiation of an effective treatment. While the average interval 
between presentation to an eye care service and confirmation 
of the diagnosis of fungal keratitis in the UK is 31 days, the 
diagnosis in our case took 19 days to confirm. However, we 
believe that this delay can be even further reduced to be able 
to improve the visual outcome. Some USA hospitals have a 
policy to investigate patients with unexplained fungal infec-
tions for concomitant immunosuppression, and a similar 
policy should be introduced in our hospital as well, if not 
nationally as we advocate.
A number of factors delayed our diagnosis and manage-
ment of this case. The vague history of trauma or chemical 
injury given by the patient was one of the factors. The first 
lesson is that we must never use steroids unless the underlying 
factors have been identified. When the pH is normal there is 
no reason to use steroids.
The second lesson is that if the patient is not improving 
after a chemical injury, this should alert us for a possible 
secondary infection of the cornea, which could be of any 
nature, including fungal. It should also make us think that 
the immune system of the patient is compromised, such as 
in HIV .Clinical Ophthalmology
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The initial corneal scrapings did not show any growth 
of microorganisms, so the third lesson is to repeat corneal 
scrapings if there was no clinical improvement within 
48 hours.
The fact that the patient took her own discharge made 
the appropriate management of this case even more difficult. 
Also, in unusual or difficult to treat cases of corneal ulcer-
ation, we need to perform HIV serologic positivity testing. 
Finally, collaboration with genitourinary specialists is highly 
recommended when such cases are suspected.
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